Keyphrases
Stomach
100%
Genetic Modification
100%
Mucinous Carcinoma
100%
Mucinous Gastric Carcinoma
100%
Tumor
21%
Propensity Score Matching
14%
No Significant Difference
14%
Advanced Stage
14%
Disease-free Survival
14%
Gastric Cancer Patients
14%
Independent Prognostic Factor
14%
Multivariate Analysis
7%
Clinical Impact
7%
Reaction Types
7%
Overall Survival
7%
5-year Survival
7%
Nine-level
7%
T Category
7%
Carbohydrate Antigen 19-9 (CA19-9)
7%
Genetic mutation
7%
Helicobacter Pylori Infection
7%
Poorly Differentiated Tumor
7%
Gastric Carcinoma Cells
7%
Epstein-Barr Virus Infections
7%
Curative Surgery
7%
Programmed Death-ligand 1 (PD-L1)
7%
Recurrence Pattern
7%
Diffuse Type
7%
Stromal Reaction
7%
Microsatellite Instability-high (MSI-H)
7%
Non-mucinous
7%
Programmed Death-ligand 1 Expression
7%
Medicine and Dentistry
Gene Mutation
100%
Mucinous Carcinoma
100%
Stomach Carcinoma
100%
Neoplasm
28%
Overall Survival
14%
Prognostic Factor
14%
Disease Free Survival
14%
Propensity Score Matching
14%
Programmed Death 1 Ligand 1
14%
Abdominal Cancer
14%
Recurrent Disease
7%
Multivariate Analysis
7%
Carcinoma Cell
7%
Survival Rate
7%
CA 19-9 Antigen
7%
Epstein-Barr Virus Infection
7%
Helicobacter Infection
7%
Microsatellite Instability
7%
Biochemistry, Genetics and Molecular Biology
Gene Mutation
100%
Overall Survival
66%
Disease Free Survival
66%
Epstein Barr Virus
33%
Helicobacter Pylori
33%
Multivariate Analysis
33%
Survival Rate
33%
Microsatellite Instability
33%
Pharmacology, Toxicology and Pharmaceutical Science
Stomach Carcinoma
100%
Neoplasm
28%
Overall Survival
14%
Disease Free Survival
14%
Programmed Death 1 Ligand 1
14%
Abdominal Cancer
14%
Recurrent Disease
7%
Survival Rate
7%
Epstein Barr Virus Infection
7%
Helicobacter Infection
7%
CA 19-9 Antigen
7%